Use of Cxbladder in Adjudicating Atypical Bladder Cytology | Case Study

Case study discussion from our recent Virtual Dinner Program event: Use in Adjudicating Atypical Bladder Cytology
Presented by Evan Goldfischer, MD
Cxbladder is a non-invasive genomic urine test designed to detect or rule out bladder cancer in hematuria patients, and those being monitored for bladder recurrence following treatment.
Accurate rule out, reducing the need for further invasive procedures
Resolve atypical cytology and equivocal cystoscopy
Improve overall detection accuracy
Cxbladder is covered by Medicare, and comes with the option of patient in-home sampling to simplify and streamline the bladder cancer testing process.
Learn more at: www.cxbladder....